Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

Similar documents
How to present the European Vaccine Action Plan (EVAP)

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Progress in maternal and child health: Uzbekistan and WHO European Region

Targeted Diseases and Immunization. Strategic plan

Çeşme Izmir, Turkey, September 2013

3. CONCLUSIONS AND RECOMMENDATIONS

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Poliomyelitis eradication in the WHO European Region

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

Polio post-certification strategy

Recommendations for vaccination

The State of Measles and Rubella in the WHO European Region

Prevention and control of hepatitis B and C in the European Region of WHO

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

Copenhagen, Denmark, September August Malaria

Monitoring of the achievement of the health-related Millennium Development Goals

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

MEASLES AND RUBELLA ELIMINATION 2015 PACKAGE FOR ACCELERATED ACTION:

Sudan EPI Benefits From Polio Eradication Program

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

Highlighting in the WHO European Region:

Measles and Rubella Global Update SAGE 19 October 2017

Immunization highlights. European Vaccine Action Plan progress report for 2016

28th PAN AMERICAN SANITARY CONFERENCE 64th SESSION OF THE REGIONAL COMMITTEE

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES

Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters

Immunization highlights Report of the WHO Regional Office for Europe

Fifth report of Committee A

OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health

Multi-sectoral aspects of pandemic preparedness and response

European Vaccine Action Plan

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Programmatic Feasibility of Measles Elimination

1. The World Bank-GAVI Partnership and the Purpose of the Review

Re: Trust for America s Health Comments on Biennial Implementation Plan for the National Health Security Strategy

4th meeting of the European Technical Advisory Group of Experts for Immunization (ETAGE) Copenhagen, Denmark, June 2005

Economic and Social Council

World Health Organization. A Sustainable Health Sector

Social determinants of health: outcome of the World Conference on Social Determinants of Health (Rio de Janeiro, Brazil, October 2011)

2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS

SEA-FHR-1. Life-Course. Promoting Health throughout the. Department of Family Health and Research Regional Office for South-East Asia

VACCINE MARKETS OVERVIEW SESSION

Third meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) November 2014 Copenhagen, Denmark

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper

REGIONAL OFFICE FOR THE WESTERN PACIFIC BUREAU RÉGIONAL DU PACIFIQUE OCCIDENTAL MEASLES ELIMINATION

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

BUDGET AND RESOURCE ALLOCATION MATRIX

Kuala Lumpur Declaration 2007

14152/1/18 REV 1 LES/ads LIFE.2.C. Brussels, 20 November 2018 (OR. en) 14152/1/18 REV 1. Interinstitutional File: 2018/0115(NLE)

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Cancer prevention and control in the context of an integrated approach

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

Economic and Social Council

Intensifying our efforts towards a world free of the avoidable burden of NCDs

Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed

Changing the prevention paradigm for the future what Europe can do

Measles and Rubella. Fact sheets on sustainable development goals: health targets. Overview

Communicable Disease Control in Complex Emergencies

Report on MCSP Support for the Polio Switch in April 2016

Report to the. GAVI Alliance Board June 2013

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

The challenge of vaccine hesitancy in the European Union

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

Gavi s private sector engagement approach

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

2017 PROGRESS REPORT on the Every Woman Every Child Global Strategy for Women s, Children s and Adolescents Health

Action plan for the health sector response to viral hepatitis in the WHO European Region

OIE/FAO Global Conference on foot and mouth disease. The way towards global control. Paraguay: 24 to 26 June Draft Resolution version 8

WFP and the Nutrition Decade

Measles and rubella monitoring January 2015

Monthly measles and rubella monitoring report

Expanded Programme on Immunization

VIOLENCE PREVENTION ALLIANCE TERMS OF REFERENCE

Consultation on Strengthened EU cooperation against vaccine preventable diseases

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

EUROPEAN IMMUNIZATION WEEK APRIL Communications package

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30)

Need for improved post-marketing surveillance in receiving countries and suggestions on how to monitor safety of newly introduced vaccines

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

Ending Malaria in Nigeria: The WHO Agenda

Draft resolution submitted by the President of the General Assembly

Lessons Learned from SIAs:

Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC)

Economic and Social Council

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Addressing Complacency, Convenience and Confidence

GAVI Role in IPV Introductions

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

Countdown to 2015: tracking progress, fostering accountability

Transcription:

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe Progress Toward Rubella Elimination and CRS Prevention in Europe February 8-10, 2012; Rome, Italy Dragan Jankovic Vaccine Preventable Diseases & Immunization Division of Communicable Diseases, Health Security & Environment WHO Regional Office for Europe Copenhagen, Denmark

Developing the new European Policy for Health: Health 2020 Vision for Health 2020 A WHO European Region where all peoples are enabled and supported in achieving their full health potential and well-being, and in which countries, individually and jointly, work towards reducing inequalities in health within the Region and beyond. Health 2020 values Universality of the right to health and health care Equity Solidarity Sustainability Right to participate in decision making relating to personal health and the health of the society in which people live Dignity

WHO European Region: Immunization programmatic goals Immunization Systems Strengthening Accelerated Disease Control Enhanced Surveillance & Monitoring Stewardship/ sustainable financing Quality-assured vaccines, supply and safety Access to and utilization of immunization services Use of new and underutilized vaccines Communication & Advocacy Diseases with eradication & elimination goals Priority bacterial and viral diseases Communication & Advocacy Surveillance for disease control and prevention Strengthening laboratory networks Communication & Advocacy

Priorities in the current environment address the challenges Decreasing commitment (competing priorities for the health system, economic crisis) Health system reform (access to health services, weakened public health) Increasing momentum of vaccine refusals General complacency in absence of disease (low risk perception), variable public trust Anti-vaccination movement Refusal due to religious and philosophic reasons Unrecognized pockets of unimmunized and underimmunized in population - marginalized and vulnerable groups!!!

2010 - First import-related polio outbreak in the European Region since declared polio-free in 2002 Third region declared polio-free Last case of confirmed endemic wild poliovirus in the European Region was in 1998 in Turkey Last case of clinically confirmed polio in Tajikistan was in 1997 5

Number of confirmed measles cases by month and year (2004-2011) Data Source: Monthly measles and rubella data reporting to CISID Data as of Dec 2011

Member States adopted resolution at 60 th Regional Committee in September 2010

Resolution commitments Member States: Commit and give goal high priority Ensure required resources Establish National Verification Committees Engage in multisectoral partnerships Strengthen routine immunization Focus on pockets with low coverage and mobilize Supplementary immunization activities as needed European Immunization Week Strengthen health system components Strengthen surveillance, case-based WHO European Regional Office: Provide strategic direction- Strategic Plan 2011-2015 Establish Regional Verification Commission to document progress Provide technical guidance to Member States Work with Member States on addressing : vulnerable groups anti-vaccine movements

Strategic plan and regional goal for measles and rubella elimination by 2015 To eliminate endemic measles, and To eliminate endemic rubella what will lead to prevention of CRS

Key areas for action for WHO The four key elimination strategies: routine immunization, additional opportunity for immunization, surveillance and availability and use of high-quality information a) Partnerships and resource mobilization b) National immunization policy c) Economics of elimination by Member States d) Monitoring and surveillance e) NITAGs f) Verification process g) Operational research

Partnerships and resource mobilization European Centre for Disease Control and Prevention UNICEF US Centres for Disease Control and Prevention WHO Collaborating Centres National health agencies and authorities Philanthropic foundations, academic institutions, and nongovernmental organizations Civil societies Media European Immunization Week EIW WIW Resource mobilization Measles initiative US CDC The Bill & Melinda Gates Foundation Member States of the European Region

Monitoring and surveillance Case-based MR surveillance Integrated work of all surveillance segments Critical role of laboratory and genotyping Regional database and network of main referent surveillance institutions (epidemiological and laboratory) Structured, systematic and ongoing monitoring Immunization coverage Diseases surveillance All other relevant information (AEFI, surveys, studies)

Document and verify when the elimination has been achieved in the WHO EUR The Regional Verification Commission for Measles and Rubella Elimination (RVC) Jan 2012 National Verification Committees for Measles and Rubella Elimination (NVCs) of the Member States Verification of measles and rubella elimination in the European Region

Components for verification Population immunity against measles and rubella Epidemiology of measles, rubella and CRS incidence during the previous 36 months Molecular epidemiology of measles and rubella viruses Performance of measles, rubella, and CRS surveillance Sustainability of the National Immunization Program Public acceptance of the measles/rubella immunization and elimination 14

Public acceptance of the measles/rubella immunization and elimination Need for effective advocacy and information, education and communication (IEC) strategies Methods - ad hoc surveys, periodic operational research activities Eventual indicators of performance or achievements under consideration

Vulnerable populations: unimmunized and under immunized

Information to population: sensation vs. facts

Reaching every child/susceptible person: WHO Europe s efforts All in partnership with key stakeholders (e.g., Member States, ECDC, UNICEF, non-governmental organizations, civil societies) WHO vaccine communications workgroup European Region immunization communications strategy Toolkit for Member States formative research tool, communications profiling, compendium of best practices, evaluation tool Build capacity with ECDC and UNICEF/CEE-CIS on use of social marketing in immunization Advocacy for political commitment

Summary Ongoing activities Confirm commitment by implementation - need to reframe activities within the adopted resolution to optimize coverage, strengthen surveillance, meet elimination goals and respond to outbreaks Sharing of best practices, and seeking shared solutions to common threats cooperation Build capacities and implement evidence based tailored advocacy and social mobilization 20